A new study has revealed that copies of the EGFR gene show up in large numbers in oesophageal and stomach cancers.
Levels are detected by taking a blood sample or liquid biopsy which less invasive than a tissue biopsy.
Patients who test positive for EGFR can then be given more effective, targeted drugs.